Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer

Josephine Feliciano, Steven Feigenberg, Minesh Mehta

Research output: Contribution to journalReview articlepeer-review

Abstract

Over the last few decades, the integration of chemotherapy and radiation has played a crucial role in the management of locally advanced non-small cell lung cancer (NSCLC). Locally advanced NSCLC is a very heterogeneous disease. Because of this heterogeneity, advanced NSCLC can be managed in various ways depending on the bulk of disease, the comorbidities of the patient, and the expertise and resources of the treating physicians and facilities. This review describes the evolution of current treatment strategies and predicted future changes for the management of locally advanced NSCLC.

Original languageEnglish (US)
Pages (from-to)222-230
Number of pages9
JournalCancer Journal (United States)
Volume19
Issue number3
DOIs
StatePublished - May 2013
Externally publishedYes

Keywords

  • Chemoradiation
  • Chemoradiotherapy
  • Chemotherapy
  • Combined modality
  • Locally advanced
  • Non-small cell lung cancer
  • Radiation
  • Stage III

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this